Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD20m

    Last close

    USD3.57

    ▲ −2.08 (−36.81%)

    Faraday Future Intelligent Electric

    MCap

    USD10m

    Last close

    USD3.92

    ▲ −0.76 (−16.24%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Actinogen Medical – executive interview

Actinogen Medical – executive interview

Actinogen Medical — 7 videos in collection

More on this equity

Actinogen Medical is a biotechnology company developing its lead compound, Xanamem, as a revolutionary new therapy for Alzheimer’s disease, major depressive disorder and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. The cognitive dysfunction, behavioural abnormalities and neuropsychological burden associated with these conditions is significantly debilitating for patients, and there is a substantial unmet medical need for new and improved treatments.

In this interview, CEO Dr Steven Gourlay discusses the company’s lead programme, what differentiates Xanamem and its mechanism of action from other approaches used to treat memory loss, and the upcoming Phase IIb study assessing Xanamem in Alzheimer’s disease.

< Previous
Next >

You may also be interested in these:

Healthcare

Actinogen Medical – equity proposition

Healthcare

Actinogen Medical – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.